Scotland-based Innova Partnerships opens Boston office

Friday, June 15, 2012 12:02 PM

Innova Partnerships, a Scottish life sciences partnering and investment company, has opened of its first U.S. venture in Northborough, Mass., to enable the company to play a key role in the internationalization of life science companies in Scotland.

“This is a very exciting development and a significant step forward for our business,” said Dr. Steve Howell, CEO and founder of Innova Partnerships. “Our strong expertise in intellectual property and regulatory compliance also means the company is perfectly positioned to offer a conduit to E.U. markets for expanding U.S. life science companies.”

Founded in 2006, the company has a strong track record for providing investment and expert consulting services, in addition to placing key executives into fledgling life science companies. Innova Partnerships professionals have a combined experience of 150 years working with companies such as Johnson & Johnson, Alere, Nypro Med Division, Unilever, and numerous startups and university spin outs. 

The company has since evolved to offer complete and fully integrated support services for life science companies at all stages of their development extending its customer base beyond the U.K. Innova Partnerships has now set its sights on the U.S., leveraging existing relationships and collaborations to open an office in the Boston area.

“We have a great opportunity to work with European life science companies seeking to access the U.S. and North American market and can now provide a link for U.S. companies considering business in Europe,” said Lou Gaviglia, Innova Partnerships’ newly appointed U.S. president.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private á¼€nancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs